WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Thursday reported a loss of $14.1 million in its fourth quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 33 cents.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The drug delivery technology company posted revenue of $14 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $8.7 million.

For the year, the company reported a loss of $70.8 million, or $1.82 per share. Revenue was reported as $46 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News